PGEN Stock Summary and Trading Ideas (Precigen | NASDAQ:PGEN)

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Precigen trades on the NASDAQ stock market under the symbol PGEN.

As of August 18, 2026, PGEN stock price declined to $6.52 with 272,273 million shares trading.

PGEN has a beta of 1.43, meaning it tends to be more sensitive to market movements. PGEN has a correlation of 0.03 to the broad based SPY ETF.

PGEN has a market cap of $2.33 billion. This is considered a Mid Cap stock.

Last quarter Precigen reported $55 million in Revenue and $.05 earnings per share. This beat revenue expectation by $27 million and exceeded earnings estimates by $.06.

In the last 3 years, PGEN traded as high as $7.32 and as low as $.65.

The top ETF exchange traded funds that PGEN belongs to (by Net Assets): XBI, VTI, IWM, VXF, IWO.

PGEN has outperformed the market in the last year with a return of +121.8%, while the SPY ETF gained +20.7%. In the last 3 month period, PGEN beat the market returning +47.5%, while SPY returned +4.3%. However, in the most recent 2 weeks PGEN has underperformed the stock market by returning -1.4%, while SPY returned +1.5%.

PGEN support price is $6.24 and resistance is $6.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PGEN shares will trade within this expected range on the day.